Hide/Show Apps

Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer

Download
2017-12-01
TASKOPARAN, Betul
SEZA, Esin Gulce
Demirkol, Secil
TUNCER, Sinem
Stefek, Milan
Gure, Ali Osmay
Banerjee, Sreeparna
Aldo-keto reductases (including AKR1B1 and AKR1B10) constitute a family of oxidoreductases that have been implicated in the pathophysiology of diabetes and cancer, including colorectal cancer (CRC). Available data indicate that, despite their similarities in structure and enzymatic functions, their roles in CRC may be divergent. Here, we aimed to determine the expression and functional implications of AKR1B1 and AKR1B10 in CRC.